Santen Pharmaceutical. (SNPHF) Q4 2024 Earnings

7NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
0.11
0.13
0.16
0.18

Details

Expected EPS
0.150913045863
Actual EPS
0.16202853
Surprise EPS
0.01
Surprise Percent
+7.37%

Description

Santen Pharmaceutical. (SNPHF) has reported earnings of 0.16202853 per share for Q4 2024.

0 Comments

Share your thoughts